PDLI R&D Expenses

Pdl Biopharma Inc · R&D Expenses

PDLI logo

PDLI R&D Expenses

Latest reported$4.56M
PDLI TTM R&D Expenses ($25.60M → $4.56M)
High-resolution chart · PNG

PDLI r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pdl Biopharma Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
4,564,000
8,874,000
8,295,000
7,308,000
6,871,000
3,233,000
3,031,000
2,955,000
2,878,000
2,811,000
6,408,000
7,381,000
8,539,000
9,867,000
5,586,000
3,820,000
1,933,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,718,000
85,118,000
132,799,000
159,881,000
171,127,000
197,813,000
205,757,000
244,072,000
258,988,000
254,514,000
260,660,000
242,222,000
220,822,000
198,549,000
172,039,000
155,279,000
133,125,000
124,795,000
122,563,000
115,141,000
110,320,000
99,369,000
82,732,000
75,665,000
67,466,000
61,182,000
57,977,000
56,098,000
54,255,000
51,688,000
52,172,000
49,949,000
46,928,000
44,937,000
42,335,000
42,127,000
40,585,000
38,869,000
36,100,000
33,600,000
34,600,000
33,400,000
31,500,000
29,100,000
26,500,000
25,500,000
25,600,000
25,800,000
28,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.